Kwan Ting CHOW

The Chow lab focuses on investigating what constitute a protective immune response against cancer in order to design effective cancer immunotherapy. The lab combines concepts and techniques from biochemistry, molecular and cell biology, cancer biology, immunology, virology, genomics, cell and animal models, and systems biology to dissect the molecular pathways and gene regulatory networks that modulate the anti-cancer immune response. The ultimate goal of the lab is to develop vaccines and targeted therapies that harness the natural ability of our immune system to fight cancer. Current research themes include: - Characterization of immune response in solid tumors - Molecular mechanisms of effective anti-cancer immune response - Design of cancer vaccines and adjuvants More details can be found in Dr Chow’s lab website.

[2026] Cell-free therapy for alopecia via the secretome of hiPSC-derived dermal papilla cells. Hwangbo, H. (Co-first Author), Pu, A. (Co-first Author), Tan, W. (Co-first Author), Dotse, E., Sun, H., Gan, X., Park, Y.-G., Lai, Y., Park, S.-J., Choi, I., Oh, I.-R., Chow, K. T., Moon, S.-H., Kim, H.-W., Park, B. C. & Ban, K. 2026. In: Journal of Tissue Engineering. 17, 20417314261449597. RGC 21 - Publication in refereed journal [15 Jul 2026] Droplet Microfluidics-Enabled Mitochondrial Transfer from Young to Senescent MSCs to Ameliorate Cellular Senescence. Liu, Z. (Co-first Author), Wang, M. (Co-first Author), Sun, J., Lee, W. Y. W., Tsang, H. Y., Chow, K. T. & Sun, D. 15 Jul 2026. In: ACS Applied Materials and Interfaces. 18, 27, p. 37561-37572. RGC 21 - Publication in refereed journal [Jan